Lung Therapeutics

Edit info

Founded: 2013

Location: Austin, TX

Employee range: 11 - 50

Clinical stage: Clin2

Therapy area: Loculated pleural effusion

Drug types: LNG, GEN

Lead product: LTI-01

Funding: $36M C Jun 2019; $14M B Jul 2017

lungtx.com

linkedin.com

job board

Drug notes:

Also RD/Clin0 malignant pleural effusion; LTI-03 Clin1 idiopathic pulmonary fibrosis; LTI-05 RD/Clin0 cystic fibrosis; LTI-07 RD/Clin0 fibrotic conditions

About:

Lung Therapeutics is developing medicines for unmet medical needs in fibrosis and lung disease.

Jobs:

Main

Contact: recruit@workinbiotech.com